Cargando…
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report
This report regards the case of a 43 year-old HIV-positive woman who developed an episode of serious transaminase elevation during stavudine-including antiretroviral therapy. Diagnostic assessment ruled out hepatitis virus co-infection, alcohol abuse besides other possible causes of liver damage. No...
Autores principales: | Lapadula, Giuseppe, Izzo, Ilaria, Costarelli, Silvia, Cologni, Giuliana, Bercich, Luisa, Casari, Salvatore, Gambarotti, Marco, Torti, Carlo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868747/ https://www.ncbi.nlm.nih.gov/pubmed/17488516 http://dx.doi.org/10.1186/1752-1947-1-19 |
Ejemplares similares
-
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
por: Torti, Carlo, et al.
Publicado: (2011) -
Sustainable Protocol for the Synthesis of 2′,3′-Dideoxynucleoside and 2′,3′-Didehydro-2′,3′-dideoxynucleoside Derivatives
por: Martín-Nieves, Virginia, et al.
Publicado: (2022) -
Stereoselective Syntheses of 3′-Hydroxyamino-
and 3′-Methoxyamino-2′,3′-Dideoxynucleosides
por: Bose, Sritama, et al.
Publicado: (2019) -
Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received
por: Motta, Davide, et al.
Publicado: (2012) -
Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
por: Wu, Pei-Ying, et al.
Publicado: (2017)